5071.0 Issues Related to Cervical Cancer: US

Wednesday, November 7, 2007: 8:30 AM
The session focuses on the policy and program implications of factors associated with cervical cancer screening in the U.S., including factors associate with screening and challenges with screening programs and laws and policies mandating vaccination. One paper uses data from a 2002 survey to assess the relative impact of various factors (e.g. social conservatism, personal health practices and health system variables) on the likelihood of getting screened for cervical cancer in the US. This information is important because cervical cancer is preventable and treatable if detected early. Another paper describes the role of the Pap test for cervical cancer screening among women ages 30 and older and analyzes socioeconomic characteristics among women who have either not recently or have never received this cancer screening. One presenter analyzes state-level legislative data to identify states mandating insurance coverage for cervical cancer screening and treatment. The analysis addresses the extent to which insurers provide coverage in accordance with American Cancer Society guidelines and the emergence of laws requiring vaccination. Another panelist assesses cognitive and emotional responses to an HPV diagnosis among men. Male partners can play a critical role in cervical cancer prevention efforts. Understanding men’s knowledge and appraisal processes concerning and HPV diagnosis may be part of addressing issues around disclosure of an HPV diagnosis, suggesting screening, getting vaccinated and decreasing risky sexual behaviors.
Session Objectives: • To discuss the relative impact of various factors on the likelihood of getting screened for cervical cancer in the US. • Analyze access and barriers to cervical cancer screening. • List possible implications of new HPV vaccination policy guidelines on future cancer screening behaviors among women ages 30 and older. • Identify states with laws requiring insurers to provide coverage for cervical cancer screening and treatment, including HPV screening and those with cervical cancer awareness resolutions.

8:30 AM
Cognitive and emotional differences among HPV+ and HPV- men: Results of a pilot study of HPV in men in a natural history study
Ellen Daley, PhD, Anna Giuliano, PhD, Julie Baldwin, PhD, Eric R. Buhi, MPH, PhD, CHES, Ji-Hyun Lee, PhD, Susan Vadaparampil, PhD, Martha Abrahamsen, MPH, Cheryl Vamos, MPH, Stephanie Kolar, MSPH, Rasheeta Chandler, RN, MS and Erica Anstey
8:50 AM
Research, policy, and results: The human papillomavirus vaccine and state efforts to reduce cervical cancer
Carissa Baker, Jill Freudenwald, MA, Regina El Arculli, MA and Kerri M. Lowrey, JD, MPH
9:10 AM
Frequency of cervical cancer screenings among women (18-64 years) in the Philadelphia Metropolitan Area
Nicole Dreisbach, MPH, Allegra R. Gordon, MPH, Francine Axler, MPH, Lynne Kotranski, PhD, Gary Klein, PhD and Abdul Beraima, PhD

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Population, Family Planning, and Reproductive Health
Endorsed by: Women's Caucus, Maternal and Child Health, HIV/AIDS

CE Credits: CME, Health Education (CHES), Nursing